Die Universitätsmedizin Greifswald ist eine rechtsfähige Körperschaft des öffentlichen Rechts, die 2010 aus der Medizinischen Fakultät der Universität Greifswald und dem Universitätsklinikum Greifswald gebildet wurde. Sie ist eine Teilkörperschaft der Universität Greifswald.

During the past decade, Universitätsmedizin Greifswald conducted 97 clinical trials. In the 10-year time frame, 97 clinical trials started and 20 clinical trials were completed, i.e. on average, 20.6% percent of trials that started reached the finish line to date. In the past 5 years, 54 clinical trials started and 12 clinical trials were completed. i.e. 22.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Universitätsmedizin Greifswald" #1 sponsor was "University Medicine Greifswald" with 41 trials, followed by "Boehringer Ingelheim" with 8 trials sponsored, "German CLL Study Group" with 7 trials sponsored, "United Therapeutics" with 6 trials sponsored and "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 6 trials sponsored. Other sponsors include 84 different institutions and companies that sponsored additional 64 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Universitätsmedizin Greifswald" #1 collaborator was "Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)" with 5 trials as a collaborator, "University Medicine Greifswald" with 4 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 2 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator and "Deutsche Kinderkrebsstiftung" with 2 trials as a collaborator. Other collaborators include 114 different institutions and companies that were collaborators in the rest 120 trials.

According to Clinical.Site data, the most researched conditions in "Universitätsmedizin Greifswald" are "Lymphoma" (7 trials), "Pulmonary Arterial Hypertension" (7 trials), "Atrial Fibrillation" (6 trials), "Chronic Lymphocytic Leukemia" (6 trials) and "Heart Failure" (6 trials). Many other conditions were trialed in "Universitätsmedizin Greifswald" in a lesser frequency.

Most popular intervention types in "Universitätsmedizin Greifswald" are "Drug" (81 trials), "Device" (35 trials), "Other" (23 trials), "Biological" (16 trials) and "Procedure" (14 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "cyclophosphamide" (7 trials), "filgrastim" (7 trials), "vincristine sulfate" (6 trials) and "Intensive cognitive training" (5 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsmedizin Greifswald" are 142 trials for "All" genders, 12 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are 52 active trials in "Universitätsmedizin Greifswald". 2 are not yet recruiting, 31 are recruiting, 17 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 82 completed trials in Universitätsmedizin Greifswald, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsmedizin Greifswald, 2 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 54 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 9 trials, and there were also 37 trials that are defined as “Not Applicable".